Business

Trump administration signs up new company to make COVID-19 drugs in U.S.

U.S. President Donald Trump's administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to end dependence on other countries.
Source: reuters

Summary automatically generated by NewSUM A.I. from the following sources:

About the author